JO
Therapeutic Areas
Milestone Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Etripamil Nasal Spray | Paroxysmal Supraventricular Tachycardia (PSVT) | Phase 3 |
Leadership Team at Milestone Pharmaceuticals
DP
David Pitts
Chief Financial Officer
RG
Robert G. Blum
Former President and CEO, Board Member
FM
Fady Malik
Executive Vice President, Research & Development and Chief Medical Officer
WM
William M. McVearry
Senior Vice President, Technical Operations
PL
Patricia L. Johnson
Senior Vice President, Regulatory Affairs and Quality Assurance
AH
Amit Hasak
Board Member (Novo Holdings)
MD
Michael D. Casey
Board Member (former CEO of Aralez Pharmaceuticals)
CW
Christopher Wight
Board Member (Healthcare Ventures)